| Identification of factors associated with development and progression of monoclonal B-cell lymphocytosis (MBL) |
Ola Landgren |
Sylvester Comprehensive Cancer Center, University of Miami |
PLCO |
Jan 21, 2010 |
2009-0561 |
| Identification of genetic and lifestyle determinants of estrogen metabolism profiles |
Fangcheng Yuan |
Vanderbilt University Medical Center |
PLCO |
Apr 19, 2023 |
PLCO-1199 |
| Identification of High-Risk Cohorts using PLCO data for Targeted Gastric Cancer Prevention and Control Strategies |
Haejin In |
Albert Einstein College of Medicine |
PLCO |
Jan 27, 2020 |
PLCO-567 |
| Identification of histologic signatures associated with adjuvant chemotherapy benefit in non-small cell lung cancer using an artificial intelligence-based assay |
David Kozono |
Valar Labs |
PLCO |
Aug 15, 2024 |
PLCOI-1637 |
| Identification of Quantitative AI-histologic signatures associated with outcomes in colorectal cancer |
RICHARD GOLDBERG |
Valar Labs |
PLCO |
Jan 27, 2025 |
PLCOI-1794 |
| Identification of Risk Factors and Patient Populations at Risk for Developing Cancer of the Head and Neck |
Jay Piccirillo |
Washington University School of Medicine in St. Louis |
PLCO |
Jul 14, 2022 |
PLCO-1003 |
| Identify high-risk susceptibility genes for melanoma using population-based samples to follow-up on rare variants in potential melanoma susceptibility genes identified from melanoma-prone families |
Rose Yang |
NCI, DCEG, GEB |
PLCO |
Mar 7, 2014 |
2014-0017 |
| Identifying DNA methylation patterns associated with Multiple Sclerosis |
Rodney Lea |
The University of Newcastle |
PLCO |
Jul 2, 2021 |
PLCO-802 |
| Identifying histological features of lung cancer using deep learning |
Jennifer Beane |
Trustees of Boston University |
NLST |
May 11, 2021 |
NLST-794 |
| Identifying LDCT imaging features associated with second primary lung cancer risk among lung cancer patients |
Summer Han |
Stanford University School of Medicine |
NLST |
Dec 18, 2023 |
NLST-1171 |
| Identifying lethal lung cancers from non-lethal disease using CT and pathology image markers |
Peng Huang |
Johns Hopkins University |
PLCO |
Sep 20, 2017 |
2017-9001 |
| Identifying metabolomic risk factors for pancreatic cancer |
Rachael Stolzenberg-Solomon |
NCI, DCEG, NEB |
PLCO |
Sep 5, 2012 |
2012-0066 |
| Identifying novel genetic factors predisposing to inherited cardiac disorders |
Connie Bezzina |
Amsterdam Universitair Medisch Centrum |
PLCO |
Mar 25, 2024 |
PLCO-1507 |
| Identifying Optimal Cohort for Renal Cell Cancer Screening |
Yair Lotan |
University of Texas Southwestern |
NLST |
Oct 9, 2014 |
NLST-92 |
| Identifying Optimal Cohort for Renal Cell Cancer Screening |
Yair Lotan |
University of Texas Southwestern |
PLCO |
Oct 9, 2014 |
PLCO-109 |
| Identifying risk factors associated with metastatic progression from non-metastatic primary lung cancer among NLST lung cancer patients |
Summer Han |
Stanford University |
NLST |
Dec 8, 2020 |
NLST-732 |
| Identifying risk factors for breast cancer through machine learning |
Daniella Araujo |
Universidade Federal de Minas Gerais |
PLCO |
Nov 3, 2021 |
PLCO-853 |
| Identifying risk factors for colorectal neoplasia through machine learning |
Daniella Araujo |
Universidade Federal de Minas Gerais |
PLCO |
Nov 30, 2021 |
PLCO-870 |
| Identifying risk factors for depression and the role of depression in cancer |
Lei Zhang |
Uniformed Services University |
PLCO |
Aug 22, 2022 |
PLCO-1027 |
| Identifying risk factors for treatment selection in NLST |
Stuart Baker |
NCI |
NLST |
Apr 9, 2013 |
NLST-15 |
